Related Experiment Video
Updated: May 8, 2026
08:20
MRI-guided dmPFC-rTMS as a Treatment for Treatment-resistant Major Depressive Disorder
Published on: August 11, 2015
EEG connectivity changes in early response to antidepressant treatment
Aditi Kathpalia1, Ioannis Vlachos2, Jaroslav Hlinka3
1Institute of Computer Science of the Czech Academy of Sciences, Prague, 18200, Czech Republic; Indian Institute of Technology Madras, Chennai, 600036, Tamil Nadu, India.
Summary
Early antidepressant treatment response in major depressive disorder patients was indicated by changes in brain connectivity. Responders showed reduced cross-hemispheric connectivity and increased lateral asymmetry in the beta-1 band.
Area of Science:
- Neuroscience and Psychiatry
- Brain Connectivity Analysis
- Electroencephalography (EEG) Signal Processing
Background:
- Major Depressive Disorder (MDD) poses a significant challenge in identifying early treatment response.
- Electroencephalography (EEG) offers a non-invasive method to study brain activity.
- Understanding neurophysiological changes associated with treatment can optimize therapeutic strategies.
Purpose of the Study:
- To identify early indicators of antidepressant treatment response using EEG signals.
- To analyze functional brain connectivity patterns in patients with MDD before and after treatment initiation.
- To differentiate responders from non-responders based on neurophysiological markers.
Main Methods:
- Computed functional brain connectivity networks using weighted imaginary coherence and mean phase coherence across 6 EEG frequency bands.
- Estimated cross-hemispheric connectivity (CH) and lateral asymmetry (LA) from EEG data recorded at baseline (Vis1) and one week post-treatment (Vis2).
- Utilized repeated measures ANOVA and post-hoc tests to identify significant changes in connectivity measures between Vis1 and Vis2 for responders and non-responders.
Main Results:
- Responders exhibited a significant reduction in CH (CHVis2 < CHVis1) within the beta-1 (12.5-17.5 Hz) frequency band.
- Responders demonstrated a significant increase in LA (LAVis2 > LAVis1) in the beta-1 frequency band.
- No significant changes in CH or LA were observed in non-responders, highlighting the specificity of these findings.
Conclusions:
- A decrease in cross-hemispheric connectivity and an increase in lateral asymmetry in the beta-1 band are potential neurophysiological indicators of early antidepressant treatment response in MDD.
- These findings suggest that EEG-based connectivity measures can serve as early biomarkers for treatment efficacy.
- Further independent replication is necessary before clinical application of these indicators can be considered.
Related Concept Videos
01:30Electroconvulsive Therapy
Electroconvulsive therapy (ECT), or shock therapy, remains a critical biomedical intervention for severe, treatment-resistant depression. While its origins can be traced back to Hippocrates' observations that malaria-induced convulsions alleviated mental illness, modern ECT has evolved significantly from its earlier, more primitive applications. First introduced in 1938 by Ugo Cerletti and his colleagues, ECT involves inducing controlled seizures using electrical currents. In its early years,...
01:25Antidepressant Drugs: Overview
Antidepressant drugs are a class of medications primarily used for treating various mood disorders, including major depression, anxiety disorders, and other related conditions. These medicines work by modulating the neurotransmitter balance within the brain, alleviating depressive symptoms. Antidepressants can be broadly categorized into several groups according to their mechanism of action and chemical structure: Selective Serotonin Reuptake Inhibitors (SSRIs), Serotonin-Norepinephrine...